BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1697781)

  • 21. Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes.
    Nedelkoska L; Benjamins JA
    J Neurosci Res; 1998 Sep; 53(5):605-12. PubMed ID: 9726431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into binding of cholera toxin to GM1 containing membrane.
    Basu I; Mukhopadhyay C
    Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
    Yu RK; Usuki S; Itokazu Y; Wu HC
    Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding and hemagglutinating properties of the B subunit(s) of heat-labile enterotoxin isolated from human enterotoxigenic Escherichia coli.
    Sugii S; Tsuji T
    FEMS Microbiol Lett; 1990 Jan; 54(1-3):45-50. PubMed ID: 2182380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of pyrene-labeled monosialoganglioside GM1 micelles with cholera toxin.
    Picking WD
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1153-8. PubMed ID: 8216243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative studies on the binding specificities of pertussis toxin and different lectins to human erythrocytes.
    Sugii S
    Nihon Juigaku Zasshi; 1989 Aug; 51(4):685-91. PubMed ID: 2585923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin.
    Kellie S; Patel B; Pierce EJ; Critchley DR
    J Cell Biol; 1983 Aug; 97(2):447-54. PubMed ID: 6684122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholera toxin B subunit-binding and ganglioside GM1 immuno-expression are not necessarily correlated in human salivary glands.
    Kirkeby S
    Acta Odontol Scand; 2014 Nov; 72(8):694-700. PubMed ID: 24655314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of cholera toxin with ganglioside GM1 receptors in supported lipid monolayers.
    Reed RA; Mattai J; Shipley GG
    Biochemistry; 1987 Feb; 26(3):824-32. PubMed ID: 3567148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside localization on myelinated nerve fibres by cholera toxin binding.
    Ganser AL; Kirschner DA; Willinger M
    J Neurocytol; 1983 Dec; 12(6):921-38. PubMed ID: 6363631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by lactoferrin and kappa-casein glycomacropeptide of binding of Cholera toxin to its receptor.
    Kawasaki Y; Isoda H; Tanimoto M; Dosako S; Idota T; Ahiko K
    Biosci Biotechnol Biochem; 1992 Feb; 56(2):195-8. PubMed ID: 1368296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in epitopes of the B subunit of Vibrio cholerae non-O1 and Vibrio mimicus cholera toxins.
    Tamplin ML; Jalali R; Ahmed MK; Colwell RR
    Can J Microbiol; 1990 Jun; 36(6):409-13. PubMed ID: 1697780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine.
    Holmgren J; Lönnroth I; Månsson J; Svennerholm L
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2520-4. PubMed ID: 1058471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cholera toxin binding to membrane receptors by pig gastric mucin-derived glycopeptides: differential effect depending on the ABO blood group antigenic determinants.
    Monferran CG; Roth GA; Cumar FA
    Infect Immun; 1990 Dec; 58(12):3966-72. PubMed ID: 1701416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus.
    Pang H; Le PU; Nabi IR
    J Cell Sci; 2004 Mar; 117(Pt 8):1421-30. PubMed ID: 14996913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomolar cholera toxin inhibitors based on symmetrical pentavalent ganglioside GM1os-sym-corannulenes.
    Mattarella M; Garcia-Hartjes J; Wennekes T; Zuilhof H; Siegel JS
    Org Biomol Chem; 2013 Jul; 11(26):4333-4339. PubMed ID: 23736158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
    Kirkeby S; Lynge Pedersen AM
    Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin.
    Buckley NE; Su Y; Milstien S; Spiegel S
    Biochim Biophys Acta; 1995 Jun; 1256(3):275-83. PubMed ID: 7786888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the role of the carboxyl group of sialic acid in binding of cholera toxin to the receptor glycosphingolipid, GM1.
    Lanne B; Schierbeck B; Karlsson KA
    J Biochem; 1994 Dec; 116(6):1269-74. PubMed ID: 7706216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.
    Sack DA; Lastovica AJ; Chang SH; Pazzaglia G
    J Clin Microbiol; 1998 Jul; 36(7):2043-5. PubMed ID: 9650959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.